Details for 2022826859

Up to date per 04.04.2026

Actions

Title / Product Name

VERWENDUNG VON MARIBAVIR ZUR BEHANDLUNG VON CYTOMEGALOVIRUS INFEKTION UND BEHANDLUNGSSCHEMATA DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2022826859

EP Publication Number

4433065

E-Number

1895775

Language

PCT Number

US22050341

Publication Date

25.09.2024 A

11.03.2026 B1

Registration Date

11.03.2026

AT Publication Date

15.04.2026

Application Date

18.11.2022

Registration Number

Priorities

19.11.2021

202163281206 P

IPC

A61K 31/7056 20060101AFI20230526BHEP

Maximum Duration of Protection

18.11.2042

Owner

Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045JP

Representative

No representatives present

Inventor

SONG, Heng Lexington, MA 02421US

SUN, Kefeng Lexington, MA 02421US

CROUTHAMEL, Matthew Lexington, MA 02421US

CHEN, Grace Lexington, MA 02421US

ZHU, Andy Z.X. Lexington, MA 02421US

MICHON, Ingrid Nicolle Princeton, NJ 08540US

BURT, Howard James Princeton, NJ 08540US

BARTER, Zoe Elizabeth Princeton, NJ 08540US

NEUHOFF, Sibylle Princeton, NJ 08540US

Information about Fees